[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0116185D0 - Substances - Google Patents

Substances

Info

Publication number
GB0116185D0
GB0116185D0 GBGB0116185.0A GB0116185A GB0116185D0 GB 0116185 D0 GB0116185 D0 GB 0116185D0 GB 0116185 A GB0116185 A GB 0116185A GB 0116185 D0 GB0116185 D0 GB 0116185D0
Authority
GB
United Kingdom
Prior art keywords
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0116185.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0116185.0A priority Critical patent/GB0116185D0/en
Publication of GB0116185D0 publication Critical patent/GB0116185D0/en
Priority to AU2002317946A priority patent/AU2002317946A1/en
Priority to PCT/GB2002/003045 priority patent/WO2003004524A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0116185.0A 2001-07-02 2001-07-02 Substances Ceased GB0116185D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0116185.0A GB0116185D0 (en) 2001-07-02 2001-07-02 Substances
AU2002317946A AU2002317946A1 (en) 2001-07-02 2002-07-02 Apicomplexa parasites secreted proteins
PCT/GB2002/003045 WO2003004524A2 (en) 2001-07-02 2002-07-02 Apicomplexa parasites secreted proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0116185.0A GB0116185D0 (en) 2001-07-02 2001-07-02 Substances

Publications (1)

Publication Number Publication Date
GB0116185D0 true GB0116185D0 (en) 2001-08-22

Family

ID=9917808

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0116185.0A Ceased GB0116185D0 (en) 2001-07-02 2001-07-02 Substances

Country Status (3)

Country Link
AU (1) AU2002317946A1 (en)
GB (1) GB0116185D0 (en)
WO (1) WO2003004524A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022162588A1 (en) * 2021-01-28 2022-08-04 Cambridge Enterprise Limited Method of treatment of malaria by targetting open reading frames

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003517284A (en) * 1999-04-15 2003-05-27 チルドレンズ メディカル センター コーポレーション Methods and compositions for modulating an immune response

Also Published As

Publication number Publication date
AU2002317946A1 (en) 2003-01-21
WO2003004524A2 (en) 2003-01-16
WO2003004524A3 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
DE50202400D1 (en) Baw-resonator
DE50201180D1 (en) Organopolysiloxan/polyharnstoff/polyurethan-blockcopolymere
DE50209614D1 (en) 2-heteroarylcarbonsäureamide
DE50211022D1 (en) Heteroarylcarbonsäureamide
DE60141364D1 (en) Polyphenylensulfidharzzusammensetzung
DE50202633D1 (en) Ophthalmoskop
DE60141362D1 (en) Ösophagus-stoma-knopf
AU2002360430A8 (en) 14-methyl-epothilones
DE60107296D1 (en) Kabelverstärkerverbindungsanordnung
DE50203686D1 (en) Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate
DE50206483D1 (en) Displaymodul
GB0114533D0 (en) Substances
GB0107628D0 (en) Substances
DE50214962D1 (en) Heterocyclylarylsulfonamide
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
GB0115071D0 (en) Substances
AU2002313943A8 (en) Electromobile
GB0116185D0 (en) Substances
AU2001100134A4 (en) Enviro-trap
GB0126402D0 (en) Substances
GB0121187D0 (en) Substances
GB0120235D0 (en) Substances
GB0116184D0 (en) Substances
GB0107630D0 (en) Substances
CA93647S (en) Fauteuil

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)